Announcements
- Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
- Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
- Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
- Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
- Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN
- Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT
- Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity
- Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
- Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED
- Hofseth Biocare ASA: EGM Notice Correction
More ▼
Key statistics
On Friday, Hofseth Biocare ASA (HBQ:FRA) closed at 0.1765, 14.98% above the 52 week low of 0.1535 set on Apr 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.16 |
---|---|
High | 0.1765 |
Low | 0.16 |
Bid | 0.176 |
Offer | 0.183 |
Previous close | 0.16 |
Average volume | 0.00 |
---|---|
Shares outstanding | 395.08m |
Free float | 165.07m |
P/E (TTM) | -- |
Market cap | 829.67m NOK |
EPS (TTM) | -0.270 NOK |
Data delayed at least 15 minutes, as of May 03 2024 20:49 BST.
More ▼